Targeting KRAS in Lung Cancer: The Past, Present, and Future - ILCN.org (ILCN/WCLC)
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives
Targeted Therapies Are Game Changers for Lung Cancer Patients with a KRAS Mutation | Fox Chase Cancer Center - Philadelphia PA
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
Development and Preclinical Evaluation of Radiolabeled Covalent G12C-Specific Inhibitors for Direct Imaging of the Oncogenic KRAS Mutant | Molecular Pharmaceutics
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein | PNAS
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
Targeting the KRAS mutation for more effective cancer treatment | MD Anderson Cancer Center
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Partnership seeks to develop KRAS degraders for cancer therapy | Frederick National Laboratory
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
KRAS Biomarker | Colorectal Cancer Alliance
KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Targeting Mutant KRAS for Immunogenic Cell Death Induction: Trends in Pharmacological Sciences
KRAS: Kirsten RAT Sarcoma Viral Oncogenic Homolog
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells: Cell
The current state of the art and future trends in RAS-targeted cancer therapies | Nature Reviews Clinical Oncology
Sotorasib for Lung Cancers with KRAS p.G12C Mutation | NEJM
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance: Trends in Cancer
Frontiers | The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
Cureus | KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer | Article
JCM | Free Full-Text | KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Targeted Therapy for 'Undruggable' Lung Cancer Stems from Decades of UCSF Research | UC San Francisco
